![]() |
Figure 4: Serum γ-glutamyl-transferase (γ-GT) levels are decreased with NS-5 consumption. The treatments 1 – 14 columns in the figure correspond to: Group A, n = 16; 1 = BL (Baseline); 2 = NS-5 capsule (Nutrition Supplement-5); 3 = PB capsule (Placebo-starch); Group B, n = 16; 4 = BL; 5 = PB capsule; 6 = NS-5 capsule; Group C, n = 32; 7 = BL; 8 = AHA ( American Heart Association Step-1 diet); 9 = AHA + NS-5 capsule; 10 = AHA + PB capsule; Group D, n = 32; 11 = BL; 12 = AHA; 13 = AHA + PB capsule; 14 = AHA + NS-5 capsule. Data are means ± SE. Values in a column not sharing a common symbol are significantly different of various groups at A-¶ P<0.05, B-¶ P<0.05, C-¶ P<0.05, D-¶ P<0.02. Percentages of each treatment compared to baseline values are above the column. |